He was generically talking about CCR5 inhibitors as the future of biotech and the future of imuno(onco)logy. The old quarterback of the immune system line. ..."we need to stockpile immunmodulators, especially ccr5 antagonists...
CCR5-Rantes mechanism is important in cancer, Covid, HIV, maybe others deseases, 60 indications maybe..
pain pathways, neuropathic pathways..
When asked directly about LL, he replied a little evasively that the full range of such immunmodulators was needed.